North Star Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-56,550
Closed -$1.16M 1189
2021
Q4
$1.16M Hold
56,550
0.08% 212
2021
Q3
$1.22M Sell
56,550
-275
-0.5% -$6.62K 0.1% 196
2021
Q2
$1.64M Buy
56,825
+900
+2% +$24.3K 0.13% 168
2021
Q1
$1.36M Buy
+55,925
New +$1.26M 0.13% 169

Other funds holding PAHC

North Star Investment Management's PAHC Position: Q1 2022 in Review

North Star Investment Management sold out of Phibro Animal Health (PAHC) in Q1 2022, closing a stake of 56,550 shares — an estimated $1.16M sold.

North Star Investment Management first reported a position in PAHC in Q1 2021 and held it in 4 quarters. The position peaked at $1.64M in Q2 2021. 153 funds tracked by Wall St. Rank hold PAHC as of Q1 2022.

  • North Star Investment Management reported no remaining Phibro Animal Health position as of Q1 2022 after selling out during the quarter.
  • North Star Investment Management sold 56,550 Phibro Animal Health shares in Q1 2022, an estimated $1.16M.
  • North Star Investment Management first reported a position in Phibro Animal Health in Q1 2021 and held it in 4 quarters.
  • North Star Investment Management's Phibro Animal Health position peaked at $1.64M in Q2 2021.
  • 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2022.

Based on North Star Investment Management's 13F filing for Q1 2022, filed 3 May 2022.